Pirfenidone, orally active anti-inflammatory antifibrotic agent (ab141425)

Publishing research using ab141425? Please let us know so that we can cite the reference in this datasheet.

ab141425 has been referenced in 1 publication.

  • Westermeyer HD  et al. Safety and efficacy of topically applied 0.5% and 1% pirfenidone in a canine model of subconjunctival fibrosis. Vet Ophthalmol N/A:N/A (2019). PubMed: 30701645

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES, NOT FOR USE IN HUMANS"
For licensing inquiries, please contact partnerships@abcam.com

Sign up